Thyroid hormones decrease plasma 1α,25-dihydroxyvitamin D levels through transcriptional repression of the renal 25-hydroxyvitamin D3 1α-hydroxylase gene (CYP27B1)

Endocrinology

Volumn 154, Issue 2, 2013, Pages 609-622

  Kozai, Mina ^a   Yamamoto, Hironori ^a   Ishiguro, Mariko ^a   Harada, Nagakatsu ^a   Masuda, Masashi ^a,c   Kagawa, Tomohiro ^a   Takei, Yuichiro ^a,d   Otani, Ayako ^a   Nakahashi, Otoki ^a   Ikeda, Shoko ^a   Taketani, Yutaka ^a   Takeyama, Ken Ichi ^b,e   Kato, Shigeaki ^b,f,g   Takeda, Eiji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^f FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^g Soma Central Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; CALCIDIOL 1 MONOOXYGENASE; CALCIUM; FIBROBLAST GROWTH FACTOR 23; LIOTHYRONINE; MESSENGER RNA; PARATHYROID HORMONE; RETINOID X RECEPTOR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1A; THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR BETA; THYROID HORMONE RECEPTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; GENE REPRESSION; GENETIC TRANSCRIPTION; HORMONE RESPONSIVE ELEMENT; HYPERTHYROIDISM; HYPOCALCEMIA; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MALE; MOUSE; NONHUMAN; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TATA BOX; VITAMIN BLOOD LEVEL;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ANIMALS; CALCITRIOL; ENZYME REPRESSION; HUMANS; KIDNEY; KIDNEY TUBULES, PROXIMAL; MICE; RESPONSE ELEMENTS; RNA, MESSENGER; THYROID HORMONES; TRANSCRIPTION, GENETIC; TRIIODOTHYRONINE;

EID: 84872702811     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1647     Document Type: Article

References (55)

1. Kochupillai N. The physiology of vitamin D : current concepts. Indian J Med Res. 2008;127:256-262.
2. Dusso A, Brown A, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol. 2005;289:F8-F28.
3. Takeda E, Yamamoto H, Taketani Y, Miyamoto K. Vitamin D-dependent rickets type I and type II. Acta Paediatr Jpn. 1997;39:508-513. (Pubitemid 27373941)
4. Murayama A, Takeyama K, Kitanaka S, et al. Positive and negative regulations of the renal 25-hydroxyvitamin D3 1α-hydroxylase gene by parathyroid hormone, calcitonin, and 1α,25(OH)2D3 in intact animals. Endocrinology. 1999;140:2224-2231. (Pubitemid 30636463)
5. 3. Biochem Biophys Res Commun. 1998;249:11-16.
6. Yoshida T, Fujimori T, Nabeshima Y. Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1α-hydroxylase gene. Endocrinology. 2002;143:683-689. (Pubitemid 34107224)
7. Shimada T, Kakitani M, Yamazaki Y, et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitaminDmetabolism. J Clin Invest. 2004;113:561-568. (Pubitemid 38542505)
8. Anderson P, O'Loughlin P, May B, Morris H. Quantification of mRNA for the vitamin D metabolizing enzymes CYP27B1 and CYP24 and vitamin D receptor in kidney using real-time reverse transcriptase- polymerase chain reaction. J Mol Endocrinol. 2003;31:123-132. (Pubitemid 37063084)
9. Perwad F, Azam N, Zhang MY, Yamashita T, Tenenhouse HS, Portale AA. Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice. Endocrinology. 2005;146:5358-5364. (Pubitemid 41653049)
10. Song Y, Fleet J. Intestinal resistance to 1,25 dihydroxyvitamin D in mice heterozygous for the vitamin D receptor knockout allele. Endocrinology. 2007;148:1396-1402.
11. Bouillon R, Muls E, De Moor P. Influence of thyroid function on the serum concentration of 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab. 1980;51:793-797. (Pubitemid 10024732)
12. Jastrup B, Mosekilde L, Melsen F, Lund B, Sørensen O. Serum levels of vitamin D metabolites and bone remodelling in hyperthyroidism. Metabolism. 1982;31:126-132. (Pubitemid 12222526)
13. Yamashita H, Noguchi S, Takatsu K, et al. High prevalence of vitamin D deficiency in Japanese female patients with Graves' disease. Endocr J. 2001;48:63-69. (Pubitemid 32230386)
14. MacFarlane I, Mawer E, Berry J, Hann J. Vitamin D metabolism in hyperthyroidism. Clin Endocrinol (Oxf). 1982;17:51-59. (Pubitemid 12127968)
15. Yamashita H, Yamazaki Y, Hasegawa H, et al. Fibroblast growth factor-23 in patients with Graves' disease before and after antithyroid therapy: its important role in serum phosphate regulation. J Clin Endocrinol Metab. 2005;90:4211-4215. (Pubitemid 41058199)
16. Pantazi H, Papapetrou P. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. J Clin Endocrinol Metab. 2000;85:1099-1106. (Pubitemid 32269356)
17. 3 metabolism in the perfused rat kidney. Endocrinology. 1984;114:330-336.
18. Alcalde A, Sarasa M, Raldúa D, et al. Role of thyroid hormone in regulation of renal phosphate transport in young and aged rats. Endocrinology. 1999;140:1544-1551. (Pubitemid 29149220)
19. Ishiguro M, Yamamoto H, Masuda M, et al. Thyroid hormones regulate phosphate homoeostasis through transcriptional control of the renal type IIa sodium-dependent phosphate co-transporter (Npt2a) gene. Biochem J. 2010;427:161-169.
20. Cheng SY, Leonard JL, Davis PJ. Molecular aspects of thyroid hormone actions. Endocr Rev. 2010;31:139-170.
21. Segawa H, Onitsuka A, Kuwahata M, et al. Type IIc sodium-dependent phosphate transporter regulates calcium metabolism. J Am Soc Nephrol. 2009;20:104-113.
22. Yamamoto H, Tani Y, Kobayashi K, et al. Alternative promoters and renal cell-specific regulation of the mouse type IIa sodium-dependent phosphate cotransporter gene. Biochim Biophys Acta. 2005;1732:43-52.
23. Harada N, Yonemoto H, Yoshida M, et al. Alternative splicing produces a constitutively active form of human SREBP-1. Biochem Biophys Res Commun. 2008;368:820-826.
24. Arai H, Miyamoto K, Taketani Y, et al. A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res. 1997;12:915-921. (Pubitemid 27225001)
25. 3 and PTH in renal proximal tubular cells. J Mol Endocrinol. 2009;42:261-268.
26. 3. Identification of a vitamin D-responsive element in the human NAPi-3 gene. J Biol Chem. 1998;273:14575-14581.
27. Cachefo A, Boucher P, Vidon C, Dusserre E, Diraison F, Beylot M. Hepatic lipogenesis and cholesterol synthesis in hyperthyroid patients. J Clin Endocrinol Metab. 2001;86:5353-5357. (Pubitemid 33070259)
28. Schapira M, Raaka BM, et al. Discovery of diverse thyroid hormone receptor antagonists by high-throughput docking. Proc Natl Acad Sci U S A. 2003;100:7354-7359. (Pubitemid 36706441)
29. Briggs MR, Yokoyama C, Wang X, Brown MS, Goldstein JL. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. I. Identification of the protein and delineation of its target nucleotide sequence. J Biol Chem. 1993;268:14490-14496. (Pubitemid 23195580)
30. Bennett MK, Lopez JM, Sanchez HB, Osborne TF. Sterol regulation of fatty acid synthase promoter. Coordinate feedback regulation of two major lipid pathways. J Biol Chem. 1995;270:25578-25583.
31. Raghow R, Yellaturu C, Deng X, Park EA, Elam MB. SREBPs: the crossroads of physiological and pathological lipid homeostasis. Trends Endocrinol Metab. 2008;19:65-73. (Pubitemid 351317897)
32. Kim JB, Sarraf P, Wright M, et al. Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. J Clin Invest. 1998;101:1-9. (Pubitemid 28058896)
33. Sasaki S, Lesoon-Wood L, Dey A, et al. Ligand-induced recruitment of a histone deacetylase in the negative-feedback regulation of the thyrotropin β gene. EMBO J. 1999;18:5389-5398. (Pubitemid 29465588)
34. Ortiga-Carvalho TM, Shibusawa N, Nikrodhanond A, et al. Negative regulation by thyroid hormone receptor requires an intact co-activator-binding surface. J Clin Invest. 2005;115:2517-2523. (Pubitemid 41266214)
35. Machado DS, Sabet A, Santiago LA, et al. A thyroid hormone receptor mutation that dissociates thyroid hormone regulation of gene expression in vivo. Proc Natl Acad SciUSA. 2009;106:9441-9446.
36. Shibusawa N, Hashimoto K, Nikrodhanond AA, et al. Thyroid hormone action in the absence of thyroid hormone receptor DNA-binding in vivo. J Clin Invest. 2003;112:588-597. (Pubitemid 38056343)
37. Euzet S, Lelièvre-Pégorier M, Merlet-Bénichou C. Effect of 3,5,3′-triiodothyronine on maturation of rat renal phosphate transport: kinetic characteristics and phosphate transporter messenger ribonucleic acid and protein abundance. Endocrinology. 1996;137:3522-3530. (Pubitemid 26250207)
38. 3 production. J Biol Chem. 2003;278:2206-2211.
39. Haldimann B, Kaptein EM, Singer FR, Nicoloff JT, Massry SG. Intestinal calcium absorption in patients with hyperthyroidism. J Clin Endocrinol Metab. 1980;51:995-997. (Pubitemid 11225449)
40. Britto JM, Fenton AJ, Holloway WR, Nicholson GC. Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption. Endocrinology. 1994;134:169-176. (Pubitemid 24021985)
41. Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, et al. The parathyroid is a target organ for FGF23 in rats. J Clin Invest. 2007;117:4003-4008. (Pubitemid 350224109)
42. Chiamolera MI, Wondisford FE. Thyrotropin-releasing hormone and the thyroid hormone feedback mechanism. Endocrinology. 2009;150:1091-1096.
43. 3 enhances thyrotropin releasing hormone induced thyrotropin secretion in normal pituitary cells. Endocrinology. 1987;121:1192-1194.
44. 3-1α-hydroxylase in mice via the long form of the leptin receptor. Arch Biochem Biophys. 2007;463:118-127.
45. Murayama A, Kim M, Yanagisawa J, Takeyama K, Kato S. Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching. EMBO J. 2004;23:1598-1608. (Pubitemid 38579520)
46. 3-mediated negative regulation of the human CYP27B1 gene. Nucleic Acids Res. 2007;35:2734-2747.
47. Gao XH, Dwivedi PP, Choe S, et al. Basal and parathyroid hormone induced expression of the human 25-hydroxyvitamin D 1α-hydroxylase gene promoter in kidney AOK-B50 cells: role of Sp1, Ets and CCAAT box protein binding sites. Int J Biochem Cell Biol. 2002;34:921-930. (Pubitemid 34499590)
48. 3 1α-hydroxylase gene. J Biol Chem. 2009;284:11059-11069.
49. Santos GM, Fairall L, Schwabe JW. Negative regulation by nuclear receptors: a plethora of mechanisms. Trends Endocrinol Metab. 2011;22:87-93.
50. Hollenberg AN, Monden T, Flynn TR, Boers ME, Cohen O, Wondisford FE. The human thyrotropin-releasing hormone gene is regulated by thyroid hormone through two distinct classes of negative thyroid hormone response elements. Mol Endocrinol. 1995;9:540-550.
51. Menéndez-Hurtado A, Santos A, Pérez-Castillo A. Characterization of the promoter region of the rat CCAAT/enhancer-binding protein α gene and regulation by thyroid hormone in rat immortalized brown adipocytes. Endocrinology. 2000;141:4164-4170.
52. Oliner JD, Andresen JM, Hansen SK, Zhou S, Tjian R. SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein. Genes Dev. 1996;10:2903-2911. (Pubitemid 26394250)
53. Hashimoto K, Yamada M, Matsumoto S, Monden T, Satoh T, Mori M. Mouse sterol response element binding protein-1c gene expression is negatively regulated by thyroid hormone. Endocrinology. 2006;147:4292-4302. (Pubitemid 44268380)
54. 3-1 α-hydroxylase. J Clin Endocrinol Metab. 2001;86:888-894.
55. Christakos S, DeLuca HF. Minireview: vitamin D, is there a role in extraskeletal health? Endocrinology. 2011;152:2930-2936.